Annual Revenue
$9.84 B
-$337.80 M-3.32%
31 December 2023
Summary:
Biogen annual revenue is currently $9.84 billion, with the most recent change of -$337.80 million (-3.32%) on 31 December 2023. During the last 3 years, it has fallen by -$3.61 billion (-26.84%). BIIB annual revenue is now -31.59% below its all-time high of $14.38 billion, reached on 31 December 2019.BIIB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$2.47 B
+$900.00 K+0.04%
30 September 2024
Summary:
Biogen quarterly revenue is currently $2.47 billion, with the most recent change of +$900.00 thousand (+0.04%) on 30 September 2024. Over the past year, it has dropped by -$64.50 million (-2.55%). BIIB quarterly revenue is now -33.02% below its all-time high of $3.68 billion, reached on 30 June 2020.BIIB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$9.61 B
-$64.50 M-0.67%
30 September 2024
Summary:
Biogen TTM revenue is currently $9.61 billion, with the most recent change of -$64.50 million (-0.67%) on 30 September 2024. Over the past year, it has dropped by -$385.80 million (-3.86%). BIIB TTM revenue is now -33.68% below its all-time high of $14.49 billion, reached on 30 June 2020.BIIB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIIB Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.3% | -2.5% | -3.9% |
| 3 y3 years | -26.8% | -11.3% | -13.4% |
| 5 y5 years | -26.9% | -31.5% | -32.5% |
BIIB Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -26.8% | at low | -11.3% | +7.7% | -13.4% | at low |
| 5 y | 5 years | -31.6% | at low | -33.0% | +7.7% | -33.7% | at low |
| alltime | all time | -31.6% | >+9999.0% | -33.0% | +658.2% | -33.7% | >+9999.0% |
Biogen Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.47 B(+0.0%) | $9.61 B(-0.7%) |
| June 2024 | - | $2.46 B(+7.6%) | $9.67 B(+0.1%) |
| Mar 2024 | - | $2.29 B(-4.0%) | $9.66 B(-1.8%) |
| Dec 2023 | $9.84 B(-3.3%) | $2.39 B(-5.7%) | $9.84 B(-1.6%) |
| Sept 2023 | - | $2.53 B(+3.0%) | $9.99 B(+0.2%) |
| June 2023 | - | $2.46 B(-0.3%) | $9.97 B(-1.3%) |
| Mar 2023 | - | $2.46 B(-3.2%) | $10.10 B(-0.7%) |
| Dec 2022 | $10.17 B(-7.4%) | $2.54 B(+1.4%) | $10.17 B(-1.8%) |
| Sept 2022 | - | $2.51 B(-3.1%) | $10.36 B(-2.5%) |
| June 2022 | - | $2.59 B(+2.3%) | $10.63 B(-1.7%) |
| Mar 2022 | - | $2.53 B(-7.4%) | $10.82 B(-1.5%) |
| Dec 2021 | $10.98 B(-18.3%) | $2.73 B(-1.6%) | $10.98 B(-1.1%) |
| Sept 2021 | - | $2.78 B(+0.1%) | $11.10 B(-5.1%) |
| June 2021 | - | $2.77 B(+3.0%) | $11.70 B(-7.2%) |
| Mar 2021 | - | $2.69 B(-5.6%) | $12.60 B(-6.3%) |
| Dec 2020 | $13.44 B(-6.5%) | $2.85 B(-15.5%) | $13.44 B(-5.7%) |
| Sept 2020 | - | $3.38 B(-8.3%) | $14.26 B(-1.5%) |
| June 2020 | - | $3.68 B(+4.2%) | $14.49 B(+0.4%) |
| Mar 2020 | - | $3.53 B(-3.7%) | $14.42 B(+0.3%) |
| Dec 2019 | $14.38 B(+6.9%) | $3.67 B(+2.0%) | $14.38 B(+1.0%) |
| Sept 2019 | - | $3.60 B(-0.5%) | $14.23 B(+1.1%) |
| June 2019 | - | $3.62 B(+3.6%) | $14.07 B(+1.9%) |
| Mar 2019 | - | $3.49 B(-1.0%) | $13.81 B(+2.7%) |
| Dec 2018 | $13.45 B(+9.6%) | $3.53 B(+2.5%) | $13.45 B(+1.7%) |
| Sept 2018 | - | $3.44 B(+2.5%) | $13.23 B(+2.8%) |
| June 2018 | - | $3.36 B(+7.2%) | $12.87 B(+2.2%) |
| Mar 2018 | - | $3.13 B(-5.3%) | $12.59 B(+2.6%) |
| Dec 2017 | $12.27 B(+7.2%) | $3.31 B(+7.4%) | $12.27 B(+3.7%) |
| Sept 2017 | - | $3.08 B(-0.0%) | $11.84 B(+1.0%) |
| June 2017 | - | $3.08 B(+9.5%) | $11.72 B(+1.6%) |
| Mar 2017 | - | $2.81 B(-2.1%) | $11.53 B(+0.7%) |
| Dec 2016 | $11.45 B(+6.4%) | $2.87 B(-2.8%) | $11.45 B(+0.3%) |
| Sept 2016 | - | $2.96 B(+2.1%) | $11.42 B(+1.6%) |
| June 2016 | - | $2.89 B(+6.1%) | $11.24 B(+2.8%) |
| Mar 2016 | - | $2.73 B(-4.0%) | $10.94 B(+1.6%) |
| Dec 2015 | $10.76 B(+10.9%) | $2.84 B(+2.2%) | $10.76 B(+1.9%) |
| Sept 2015 | - | $2.78 B(+7.2%) | $10.57 B(+2.6%) |
| June 2015 | - | $2.59 B(+1.4%) | $10.30 B(+1.7%) |
| Mar 2015 | - | $2.55 B(-3.2%) | $10.13 B(+4.4%) |
| Dec 2014 | $9.70 B(+40.0%) | $2.64 B(+5.1%) | $9.70 B(+7.5%) |
| Sept 2014 | - | $2.51 B(+3.7%) | $9.03 B(+8.2%) |
| June 2014 | - | $2.42 B(+13.7%) | $8.34 B(+9.1%) |
| Mar 2014 | - | $2.13 B(+8.3%) | $7.65 B(+10.3%) |
| Dec 2013 | $6.93 B(+25.7%) | $1.97 B(+7.6%) | $6.93 B(+8.6%) |
| Sept 2013 | - | $1.83 B(+6.1%) | $6.38 B(+7.4%) |
| June 2013 | - | $1.72 B(+21.8%) | $5.94 B(+5.4%) |
| Mar 2013 | - | $1.42 B(-0.2%) | $5.64 B(+2.2%) |
| Dec 2012 | $5.52 B(+9.3%) | $1.42 B(+2.3%) | $5.52 B(-10.5%) |
| Sept 2012 | - | $1.39 B(-2.5%) | $6.16 B(+5.9%) |
| June 2012 | - | $1.42 B(+10.0%) | $5.82 B(+3.8%) |
| Mar 2012 | - | $1.29 B(-37.5%) | $5.61 B(+1.6%) |
| Dec 2011 | $5.05 B(+7.0%) | $2.07 B(+98.0%) | $5.52 B(+18.1%) |
| Sept 2011 | - | $1.04 B(-13.7%) | $4.67 B(-2.8%) |
| June 2011 | - | $1.21 B(+0.4%) | $4.81 B(-0.1%) |
| Mar 2011 | - | $1.20 B(-1.3%) | $4.81 B(+2.0%) |
| Dec 2010 | $4.72 B(+7.7%) | $1.22 B(+3.7%) | $4.72 B(+2.0%) |
| Sept 2010 | - | $1.18 B(-3.0%) | $4.62 B(+1.2%) |
| June 2010 | - | $1.21 B(+9.4%) | $4.57 B(+2.7%) |
| Mar 2010 | - | $1.11 B(-1.6%) | $4.45 B(+1.7%) |
| Dec 2009 | $4.38 B(+6.8%) | $1.13 B(+0.6%) | $4.38 B(+1.3%) |
| Sept 2009 | - | $1.12 B(+2.5%) | $4.32 B(+0.6%) |
| June 2009 | - | $1.09 B(+5.5%) | $4.29 B(+2.4%) |
| Mar 2009 | - | $1.04 B(-3.0%) | $4.19 B(+2.3%) |
| Dec 2008 | $4.10 B(+29.2%) | $1.07 B(-2.2%) | $4.10 B(+4.5%) |
| Sept 2008 | - | $1.09 B(+10.0%) | $3.92 B(+8.4%) |
| June 2008 | - | $993.44 M(+5.4%) | $3.62 B(+6.5%) |
| Mar 2008 | - | $942.19 M(+5.5%) | $3.40 B(+7.1%) |
| Dec 2007 | $3.17 B(+18.2%) | $893.30 M(+13.2%) | $3.17 B(+6.2%) |
| Sept 2007 | - | $789.23 M(+2.1%) | $2.99 B(+3.0%) |
| June 2007 | - | $773.18 M(+8.0%) | $2.90 B(+4.1%) |
| Mar 2007 | - | $715.91 M(+1.1%) | $2.79 B(+3.9%) |
| Dec 2006 | $2.68 B(+56.6%) | $708.34 M(+0.7%) | $2.68 B(+41.3%) |
| Sept 2006 | - | $703.49 M(+6.6%) | $1.90 B(+6.0%) |
| June 2006 | - | $660.04 M(+8.0%) | $1.79 B(+3.1%) |
| Mar 2006 | - | $611.17 M(-903.9%) | $1.74 B(+1.4%) |
| Dec 2005 | $1.71 B(+7.4%) | -$76.03 M(-112.8%) | $1.71 B(-2.7%) |
| Sept 2005 | - | $596.21 M(-1.6%) | $1.76 B(+3.1%) |
| June 2005 | - | $605.63 M(+3.0%) | $1.71 B(+4.1%) |
| Mar 2005 | - | $587.80 M(-2202.1%) | $1.64 B(+2.9%) |
| Dec 2004 | $1.60 B | -$27.96 M(-105.1%) | $1.60 B(+11.6%) |
| Sept 2004 | - | $543.28 M(+0.8%) | $1.43 B(+39.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $538.76 M(-0.5%) | $1.03 B(+68.0%) |
| Mar 2004 | - | $541.74 M(-380.4%) | $610.63 M(+228.1%) |
| Dec 2003 | $186.13 M(-54.0%) | -$193.20 M(-239.5%) | $186.13 M(-398.4%) |
| Sept 2003 | - | $138.53 M(+12.1%) | -$62.37 M(-171.3%) |
| June 2003 | - | $123.56 M(+5.4%) | $87.42 M(-62.5%) |
| Mar 2003 | - | $117.25 M(-126.5%) | $233.13 M(-42.3%) |
| Dec 2002 | $404.22 M(-61.2%) | -$441.71 M(-253.2%) | $404.22 M(-64.1%) |
| Sept 2002 | - | $288.33 M(+7.1%) | $1.13 B(+2.1%) |
| June 2002 | - | $269.26 M(-6.6%) | $1.10 B(+0.8%) |
| Mar 2002 | - | $288.34 M(+3.2%) | $1.09 B(+4.9%) |
| Dec 2001 | $1.04 B(+12.6%) | $279.41 M(+5.4%) | $1.04 B(+3.5%) |
| Sept 2001 | - | $265.19 M(+1.8%) | $1.01 B(+3.2%) |
| June 2001 | - | $260.58 M(+9.9%) | $975.93 M(+3.2%) |
| Mar 2001 | - | $237.05 M(-3.1%) | $945.86 M(+2.2%) |
| Dec 2000 | $925.66 M(+16.5%) | $244.55 M(+4.6%) | $925.66 M(+2.1%) |
| Sept 2000 | - | $233.75 M(+1.4%) | $906.45 M(+2.9%) |
| June 2000 | - | $230.51 M(+6.3%) | $881.10 M(+5.0%) |
| Mar 2000 | - | $216.85 M(-3.8%) | $839.51 M(+5.7%) |
| Dec 1999 | $794.43 M(+42.5%) | $225.34 M(+8.1%) | $794.38 M(+7.7%) |
| Sept 1999 | - | $208.40 M(+10.3%) | $737.44 M(+9.3%) |
| June 1999 | - | $188.93 M(+10.0%) | $674.94 M(+9.8%) |
| Mar 1999 | - | $171.72 M(+2.0%) | $614.81 M(+10.3%) |
| Dec 1998 | $557.59 M(+28.5%) | $168.39 M(+15.4%) | $557.59 M(+4.2%) |
| Sept 1998 | - | $145.90 M(+13.3%) | $535.34 M(+9.2%) |
| June 1998 | - | $128.80 M(+12.5%) | $490.04 M(+8.0%) |
| Mar 1998 | - | $114.50 M(-21.7%) | $453.64 M(+4.5%) |
| Dec 1997 | $434.04 M(+56.6%) | $146.14 M(+45.3%) | $433.94 M(+10.5%) |
| Sept 1997 | - | $100.60 M(+8.9%) | $392.59 M(+1.0%) |
| June 1997 | - | $92.40 M(-2.5%) | $388.79 M(+15.2%) |
| Mar 1997 | - | $94.80 M(-9.5%) | $337.59 M(+21.8%) |
| Dec 1996 | $277.09 M(+82.7%) | $104.79 M(+8.3%) | $277.19 M(+22.9%) |
| Sept 1996 | - | $96.80 M(+135.0%) | $225.49 M(+38.7%) |
| June 1996 | - | $41.20 M(+19.8%) | $162.59 M(+5.5%) |
| Mar 1996 | - | $34.40 M(-35.2%) | $154.09 M(+1.6%) |
| Dec 1995 | $151.69 M(-3.0%) | $53.09 M(+56.6%) | $151.69 M(+7.2%) |
| Sept 1995 | - | $33.90 M(+3.7%) | $141.54 M(+1.5%) |
| June 1995 | - | $32.70 M(+2.2%) | $139.44 M(-0.1%) |
| Mar 1995 | - | $32.00 M(-25.5%) | $139.54 M(-6.2%) |
| Dec 1994 | $156.34 M(+14.6%) | $42.94 M(+35.0%) | $148.74 M(+5.5%) |
| Sept 1994 | - | $31.80 M(-3.0%) | $141.00 M(-1.5%) |
| June 1994 | - | $32.80 M(-20.4%) | $143.10 M(-1.3%) |
| Mar 1994 | - | $41.20 M(+17.0%) | $145.00 M(+6.4%) |
| Dec 1993 | $136.40 M(+10.3%) | $35.20 M(+3.8%) | $136.30 M(-10.7%) |
| Sept 1993 | - | $33.90 M(-2.3%) | $152.60 M(-2.6%) |
| June 1993 | - | $34.70 M(+6.8%) | $156.60 M(+11.9%) |
| Mar 1993 | - | $32.50 M(-36.9%) | $140.00 M(+13.3%) |
| Dec 1992 | $123.70 M(+101.5%) | $51.50 M(+35.9%) | $123.60 M(+41.3%) |
| Sept 1992 | - | $37.90 M(+109.4%) | $87.50 M(+35.9%) |
| June 1992 | - | $18.10 M(+12.4%) | $64.40 M(+4.5%) |
| Mar 1992 | - | $16.10 M(+4.5%) | $61.60 M(+0.3%) |
| Dec 1991 | $61.40 M(+22.6%) | $15.40 M(+4.1%) | $61.40 M(+2.7%) |
| Sept 1991 | - | $14.80 M(-3.3%) | $59.80 M(+4.0%) |
| June 1991 | - | $15.30 M(-3.8%) | $57.50 M(+6.1%) |
| Mar 1991 | - | $15.90 M(+15.2%) | $54.20 M(+8.2%) |
| Dec 1990 | $50.10 M(+75.8%) | $13.80 M(+10.4%) | $50.10 M(+14.4%) |
| Sept 1990 | - | $12.50 M(+4.2%) | $43.80 M(+14.4%) |
| June 1990 | - | $12.00 M(+1.7%) | $38.30 M(+15.4%) |
| Mar 1990 | - | $11.80 M(+57.3%) | $33.20 M(+12.5%) |
| Dec 1989 | $28.50 M(+38.3%) | $7.50 M(+7.1%) | $29.50 M(+6.9%) |
| Sept 1989 | - | $7.00 M(+1.4%) | $27.60 M(+14.0%) |
| June 1989 | - | $6.90 M(-14.8%) | $24.20 M(+4.8%) |
| Mar 1989 | - | $8.10 M(+44.6%) | $23.10 M(+12.1%) |
| Dec 1988 | $20.60 M(+139.5%) | $5.60 M(+55.6%) | $20.60 M(+22.6%) |
| Sept 1988 | - | $3.60 M(-37.9%) | $16.80 M(+12.0%) |
| June 1988 | - | $5.80 M(+3.6%) | $15.00 M(+37.6%) |
| Mar 1988 | - | $5.60 M(+211.1%) | $10.90 M(+28.2%) |
| Dec 1987 | $8.60 M(+34.4%) | $1.80 M(0.0%) | $8.50 M(+13.3%) |
| Sept 1987 | - | $1.80 M(+5.9%) | $7.50 M(+17.2%) |
| June 1987 | - | $1.70 M(-46.9%) | $6.40 M(-4.5%) |
| Mar 1987 | - | $3.20 M(+300.0%) | $6.70 M(+6.3%) |
| Dec 1986 | $6.40 M(-57.6%) | $800.00 K(+14.3%) | $6.30 M(-25.0%) |
| Sept 1986 | - | $700.00 K(-65.0%) | $8.40 M(-28.2%) |
| June 1986 | - | $2.00 M(-28.6%) | $11.70 M(-20.9%) |
| Mar 1986 | - | $2.80 M(-3.4%) | $14.80 M(-1.3%) |
| Dec 1985 | $15.10 M(-34.1%) | $2.90 M(-27.5%) | $15.00 M(-21.9%) |
| Sept 1985 | - | $4.00 M(-21.6%) | $19.20 M(-9.0%) |
| June 1985 | - | $5.10 M(+70.0%) | $21.10 M(-2.8%) |
| Mar 1985 | - | $3.00 M(-57.7%) | $21.70 M(-5.2%) |
| Dec 1984 | $22.90 M | $7.10 M(+20.3%) | $22.90 M(+44.9%) |
| Sept 1984 | - | $5.90 M(+3.5%) | $15.80 M(+59.6%) |
| June 1984 | - | $5.70 M(+35.7%) | $9.90 M(+135.7%) |
| Mar 1984 | - | $4.20 M | $4.20 M |
FAQ
- What is Biogen annual revenue?
- What is the all time high annual revenue for Biogen?
- What is Biogen annual revenue year-on-year change?
- What is Biogen quarterly revenue?
- What is the all time high quarterly revenue for Biogen?
- What is Biogen quarterly revenue year-on-year change?
- What is Biogen TTM revenue?
- What is the all time high TTM revenue for Biogen?
- What is Biogen TTM revenue year-on-year change?
What is Biogen annual revenue?
The current annual revenue of BIIB is $9.84 B
What is the all time high annual revenue for Biogen?
Biogen all-time high annual revenue is $14.38 B
What is Biogen annual revenue year-on-year change?
Over the past year, BIIB annual revenue has changed by -$337.80 M (-3.32%)
What is Biogen quarterly revenue?
The current quarterly revenue of BIIB is $2.47 B
What is the all time high quarterly revenue for Biogen?
Biogen all-time high quarterly revenue is $3.68 B
What is Biogen quarterly revenue year-on-year change?
Over the past year, BIIB quarterly revenue has changed by -$64.50 M (-2.55%)
What is Biogen TTM revenue?
The current TTM revenue of BIIB is $9.61 B
What is the all time high TTM revenue for Biogen?
Biogen all-time high TTM revenue is $14.49 B
What is Biogen TTM revenue year-on-year change?
Over the past year, BIIB TTM revenue has changed by -$385.80 M (-3.86%)